Heart Test Laboratories Inc. (HSCS) Fundamentals

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
SHARE INFORMATION
Market Cap$ 11,489,313
Shares Outstanding8,202,551
Float6,662,039
Percent Float81.22%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 14,373
Latest Fiscal EPS$ -0.60
Latest Fiscal Date2022-04-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions5
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.8%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 6.00
52 Week Low$ 1.14
52 Week High Change$ 0.00
21 Day Moving Average$ 2.0369
21 Day Extended Moving Average$ 1.8001
50 Day Moving Average$ 1.7114
50 Day Extended Moving Average$ 1.8108
200 Day Moving Average$ 1.7788
200 Day Extended Moving Average$ 1.755
10 Day Average Volume33,278
20 Day Average Volume47,014
30 Day Average Volume110,800
50 Day Average Volume91,952
Alpha0.135013
Beta3.2427
Standard Deviation0.610913
R20.233808
7 Day Price Change$ -0.1693
7 Day Percent Change-10.78%
21 Day Price Change$ -0.9893
21 Day Percent Change-41.39%
30 Day Price Change$ -1.08
30 Day Percent Change-43.52%
Month to Date Price Change$ -1.04
Month to Date Percent Change-42.71%
Quarter to Date Price Change$ 0.2207
Quarter to Date Percent Change18.7%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.00
Year to Date Percent Change0.0%

Heart Test Laboratories Inc. (HSCS) Key Ratios

PROFITABILITY
EBIT Margin-54,139.1%
EBITDA Margin-53,881.3%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin58.7%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 10,089
Revenue Per Share$ 0.0012
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.00
Total Debt To Equity0.40
Int Coverage-12.50
Current Ratio3.50
Leverage Ratio-2.40
Quick Ratio2.80
Long Term Debt To Capital0.26
VALUATION MEASURES
PE Ratio-1.70
Enterprise Value$ 8,408,773
Price to Sales1,138.796
Price to Free Cash-2.40
PE High Last 5 Years0.00
Price To Book4.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover12.40
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-105.97
Return on Equity-204.36
Return on Capital-133.93

Heart Test Laboratories Inc. (HSCS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorHaskell & White LLP
CEOAndrew Simpson
Emplyoees13
Last AuditUE
CIK0001468492
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers(423450)
CONTACT INFO
Address550 Reserve Street
Suite 360
Southlake, TX 76092
Websitehttps://www.heartsciences.com
Facsimile-
Telephone+1 682 237-7781
Email-


Your Recent History
NASDAQ
HSCS
Heart Test..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.